Shared and Distinct Functions of the Transcription Factors IRF4 and IRF8 in Myeloid Cell Development

Interferon regulatory factor (IRF) 8 and IRF4 are structurally-related, hematopoietic cell-specific transcription factors that cooperatively regulate the differentiation of dendritic cells and B cells. Whilst in myeloid cells IRF8 is known to modulate growth and differentiation, the role of IRF4 is poorly understood. In this study, we show that IRF4 has activities similar to IRF8 in regulating myeloid cell development. The ectopic expression of IRF4 in myeloid progenitor cells in vitro inhibits cell growth, promotes macrophages, but hinders granulocytic cell differentiation. We also show that IRF4 binds to and activates transcription through the IRF-Ets composite sequence (IECS). Furthermore, we demonstrate that Irf8 -/- Irf4 -/- mice exhibit a more severe chronic myeloid leukemia (CML)-like disease than Irf8 -/- mice, involving a disproportionate expansion of granulocytes at the expense of monocytes/macrophages. Irf4 -/- mice, however, display no obvious abnormality in myeloid cell development, presumably because IRF4 is expressed at a much lower level than IRF8 in granulocyte-macrophage progenitors. Our results also suggest that IRF8 and IRF4 have not only common but also specific activities in myeloid cells. Since the expression of both the IRF8 and IRF4 genes is downregulated in CML patients, these results may add to our understanding of CML pathogenesis.

[1]  Damien Chaussabel,et al.  IRF8 mutations and human dendritic-cell immunodeficiency. , 2011, The New England journal of medicine.

[2]  Qingshan Li,et al.  Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation , 2011, Nature communications.

[3]  Harinder Singh,et al.  Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis. , 2010, Blood.

[4]  A. Mantovani,et al.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.

[5]  K. Nakai,et al.  The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection , 2010, Nature Immunology.

[6]  H. Schild,et al.  Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. , 2010, Immunity.

[7]  Chen-feng Qi,et al.  IRF8 regulates B-cell lineage specification, commitment, and differentiation. , 2008, Blood.

[8]  T. Taniguchi,et al.  The IRF family transcription factors in immunity and oncogenesis. , 2008, Annual review of immunology.

[9]  T. Mak,et al.  The development of inflammatory TH-17 cells requires interferon-regulatory factor 4 , 2007, Nature Immunology.

[10]  Daniel G. Tenen,et al.  Transcription factors in myeloid development: balancing differentiation with transformation , 2007, Nature Reviews Immunology.

[11]  K. Ozato,et al.  IRF-8/Interferon (IFN) Consensus Sequence-binding Protein Is Involved in Toll-like Receptor (TLR) Signaling and Contributes to the Cross-talk between TLR and IFN-γ Signaling Pathways* , 2006, Journal of Biological Chemistry.

[12]  K. Honda,et al.  Negative regulation of Toll-like-receptor signaling by IRF-4. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Matsuyama,et al.  Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Ko,et al.  Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. , 2005, Blood.

[15]  Tak W. Mak,et al.  Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors , 2005, Nature.

[16]  J. O’Shea,et al.  IFN Regulatory Factor-4 and -8 Govern Dendritic Cell Subset Development and Their Functional Diversity , 2005, The Journal of Immunology.

[17]  Kazuo Suzuki,et al.  Critical roles of interferon regulatory factor 4 in CD11bhighCD8α– dendritic cell development , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. Ishii,et al.  Toll-Like Receptor 9 Signaling Activates NF-κB through IFN Regulatory Factor-8/IFN Consensus Sequence Binding Protein in Dendritic Cells1 , 2004, The Journal of Immunology.

[19]  C. Tunyaplin,et al.  ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells. , 2003, Blood.

[20]  Irving L Weissman,et al.  Biology of hematopoietic stem cells and progenitors: implications for clinical application. , 2003, Annual review of immunology.

[21]  Harinder Singh,et al.  IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. , 2003, Genes & development.

[22]  M. Slovak,et al.  Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. , 2003, Blood.

[23]  T. Mak,et al.  Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Ozato,et al.  IFN Consensus Sequence Binding Protein/IFN Regulatory Factor-8 Guides Bone Marrow Progenitor Cells Toward the Macrophage Lineage1 , 2002, Journal of Immunology.

[25]  K. Ozato,et al.  ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[26]  T. Holyoake,et al.  Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. , 2002, Blood.

[27]  M. Schmidt,et al.  Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-alpha. , 2001, Blood.

[28]  M. Schmidt,et al.  Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  K. Ozato,et al.  ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. , 2000, Immunity.

[30]  G. Trinchieri,et al.  An IFN-γ-Inducible Transcription Factor, IFN Consensus Sequence Binding Protein (ICSBP), Stimulates IL-12 p40 Expression in Macrophages , 2000, The Journal of Immunology.

[31]  J. Waring,et al.  Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. , 1999, Blood.

[32]  M. Atchison,et al.  Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages. , 1999, Journal of immunology.

[33]  J. Waring,et al.  Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. , 1998, Blood.

[34]  N. Giese,et al.  Interferon (IFN) Consensus Sequence-binding Protein, a Transcription Factor of the IFN Regulatory Factor Family, Regulates Immune Responses In Vivo through Control of Interleukin 12 Expression , 1997, The Journal of experimental medicine.

[35]  A. Sher,et al.  Interferon Consensus Sequence Binding Protein–deficient Mice Display Impaired Resistance to Intracellular Infection Due to a Primary Defect in Interleukin 12 p40 Induction , 1997, The Journal of experimental medicine.

[36]  J. Licht,et al.  Transcription factors, normal myeloid development, and leukemia. , 1997, Blood.

[37]  J. Waring,et al.  Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene , 1996, Cell.

[38]  U. Storb,et al.  Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. , 1995, Genes & development.

[39]  Wei Chen,et al.  T-cell immunity to the joining region of p210BCR-ABL protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.